Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.

Diagnosis of fascioliasis with high sensitivity and specificity antigens play a vital role in the management of the disease. Majority of commercial serological tests use F. hepatica native antigens and indicate wide diversities in test accuracy. Nowadays, recombinant antigens have been introduced as...

Full description

Bibliographic Details
Main Authors: Abolfazl Mirzadeh, Asiyeh Yoosefy, Elham Kazemirad, Zahra Barati, Majid Golkar, Jalal Babaie, Farid Jafarihaghighi, Zarrintaj Valadkhani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6169862?pdf=render
id doaj-90bc86c579c04913aae363a596eabf69
record_format Article
spelling doaj-90bc86c579c04913aae363a596eabf692020-11-25T01:23:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011310e020349010.1371/journal.pone.0203490Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.Abolfazl MirzadehAsiyeh YoosefyElham KazemiradZahra BaratiMajid GolkarJalal BabaieFarid JafarihaghighiZarrintaj ValadkhaniDiagnosis of fascioliasis with high sensitivity and specificity antigens play a vital role in the management of the disease. Majority of commercial serological tests use F. hepatica native antigens and indicate wide diversities in test accuracy. Nowadays, recombinant antigens have been introduced as diagnostic reagents offer better test standardization. A combination of highly pure recombinant antigens associated with correct folding will leads to improve specificity and sensitivity of ELISA for diagnosis of Fascioliasis. In this article, Fasciola hepatica saposin-like protein 2 (SAP-2), ferritin protein (Ftn-1) and leucine aminopeptidase (LAP) recombinant antigens were considered as tools for the detection of F. hepatica immunoglobulin G antibodies in persons with chronic human fasciolasis. The recombinant antigens were obtained as fusion proteins, expressed in Escherichia coli and purified by immobilized metal affinity chromatography (IMAC). The refolding processes of denatured recombinant proteins were performed using dialysis method in the presence of chemical additives, and reduced/oxidized glutathione (in vitro). The immunoreactivity of the recombinant antigens was assessed individually and in a combination compared with excretory/secretory antigen (E/S) in an enzyme-linked immunosorbent assay (ELISA) test. The experiments were optimized using 213 serum samples from humans, including patients with chronic fascioliasis, patients with other parasitic diseases, and healthy subjects. The results indicated 95% sensitivity and 98% specificity for rtFhSAP-2, 96% sensitivity and 91% specificity for E/S, 80% and 83.3% for rtFhFtn-1, 84% and 88% for FhLAP, and also, 96% and 95% for combination of recombinant antigens, respectively. In conclusion, the results of this investigation showed that rtFhSAP-2 with the highest specificity and acceptable sensitivity has a considerable superiority compared to mentioned antigens and even in combination with these antigens in serodiagnosis of human fascioliasis.http://europepmc.org/articles/PMC6169862?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Abolfazl Mirzadeh
Asiyeh Yoosefy
Elham Kazemirad
Zahra Barati
Majid Golkar
Jalal Babaie
Farid Jafarihaghighi
Zarrintaj Valadkhani
spellingShingle Abolfazl Mirzadeh
Asiyeh Yoosefy
Elham Kazemirad
Zahra Barati
Majid Golkar
Jalal Babaie
Farid Jafarihaghighi
Zarrintaj Valadkhani
Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
PLoS ONE
author_facet Abolfazl Mirzadeh
Asiyeh Yoosefy
Elham Kazemirad
Zahra Barati
Majid Golkar
Jalal Babaie
Farid Jafarihaghighi
Zarrintaj Valadkhani
author_sort Abolfazl Mirzadeh
title Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
title_short Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
title_full Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
title_fullStr Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
title_full_unstemmed Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
title_sort evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description Diagnosis of fascioliasis with high sensitivity and specificity antigens play a vital role in the management of the disease. Majority of commercial serological tests use F. hepatica native antigens and indicate wide diversities in test accuracy. Nowadays, recombinant antigens have been introduced as diagnostic reagents offer better test standardization. A combination of highly pure recombinant antigens associated with correct folding will leads to improve specificity and sensitivity of ELISA for diagnosis of Fascioliasis. In this article, Fasciola hepatica saposin-like protein 2 (SAP-2), ferritin protein (Ftn-1) and leucine aminopeptidase (LAP) recombinant antigens were considered as tools for the detection of F. hepatica immunoglobulin G antibodies in persons with chronic human fasciolasis. The recombinant antigens were obtained as fusion proteins, expressed in Escherichia coli and purified by immobilized metal affinity chromatography (IMAC). The refolding processes of denatured recombinant proteins were performed using dialysis method in the presence of chemical additives, and reduced/oxidized glutathione (in vitro). The immunoreactivity of the recombinant antigens was assessed individually and in a combination compared with excretory/secretory antigen (E/S) in an enzyme-linked immunosorbent assay (ELISA) test. The experiments were optimized using 213 serum samples from humans, including patients with chronic fascioliasis, patients with other parasitic diseases, and healthy subjects. The results indicated 95% sensitivity and 98% specificity for rtFhSAP-2, 96% sensitivity and 91% specificity for E/S, 80% and 83.3% for rtFhFtn-1, 84% and 88% for FhLAP, and also, 96% and 95% for combination of recombinant antigens, respectively. In conclusion, the results of this investigation showed that rtFhSAP-2 with the highest specificity and acceptable sensitivity has a considerable superiority compared to mentioned antigens and even in combination with these antigens in serodiagnosis of human fascioliasis.
url http://europepmc.org/articles/PMC6169862?pdf=render
work_keys_str_mv AT abolfazlmirzadeh evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
AT asiyehyoosefy evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
AT elhamkazemirad evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
AT zahrabarati evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
AT majidgolkar evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
AT jalalbabaie evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
AT faridjafarihaghighi evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
AT zarrintajvaladkhani evaluationofasetofrefoldedrecombinantantigensforserodiagnosisofhumanfascioliasis
_version_ 1725121564282716160